REBECCA MYERS-SETTLE: Open Payments
NPI 1922573104 · FRONT ROYAL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107 in 6 payments from 5 companies in 2025. Trend: 2023 $130 · 2024 $473 · 2025 $107
Food & beverage: $107
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
Products named: CAPLYTA, Qelbree, ARISTADA, Auvelity, VRAYLAR.
Industry payments across VA — which companies pay providers there.
